Current History

University of California Press
University of California Press
ISSN: 00113530, 1944785X

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q1
Impact factor
2.4
SJR
0.249
CiteScore
1.6
Categories
History
Areas
Arts and Humanities
Years of issue
1977, 1980, 1982, 1984, 1986, 1996, 1998-2002, 2005-2025
journal names
Current History
CURR HIST
Publications
18 620
Citations
5 814
h-index
24
Top-3 citing journals
Top-3 organizations
Columbia University
Columbia University (316 publications)
Harvard University
Harvard University (312 publications)
Yale University
Yale University (222 publications)
Top-3 countries
USA (4640 publications)
Italy (392 publications)
United Kingdom (75 publications)

Most cited in 5 years

Found 
from chars
Publications found: 277
The effect of ghrelin on antioxidant status in the rat’s model of Alzheimer's disease induced by amyloid-beta
Sarlaki F., Shahsavari Z., Goshadrou F., Naseri F., Keimasi M., Sirati-Sabet M.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 11
Open Access
Open access
Is autologous platelet activation the key step in ovarian therapy for fertility recovery and menopause reversal?
Rickers N.S., Sills E.S.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 4
Open Access
Open access
Crosstalk between Fatty Acid Metabolism and Tumour-Associated Macrophages in Cancer Progression
Zaidi N.E., Shazali N.A., Leow T.C., Osman M.A., Ibrahim K., Rahman N.M.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 12
Open Access
Open access
The expression of ACAT1 in oral squamous cell carcinoma and the adjacent pre-tumour tissue
Firouzpour H., Shokrolahi S.M., Bourova-Flin E., Derakhshan S., Shahsavari Z., Karimi A., Mir Mohammad Sadeghi H., Goudarzi A.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 4
Open Access
Open access
In silico and in vitro studies of Taiwan Chingguan Yihau (NRICM101) on TNF-α/IL-1β-induced Human Lung Cells
Cheng Y., Lu C., Hsu Y., Tsai F., Bau D., Tsai S., Cheng C., Lin J., Huang Y., Juan Y., Chiu Y., Kuo S., Yang J., Wu L.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 10
Open Access
Open access
The evaluation of serum lipid profile and Apolipoprotein C-1 in the Iranian patients of Oral Squamous Cell Carcinoma
Alazzawi W., Shahsavari Z., Babaei H., Firouzpour H., Karimi A., Goudarzi A.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 2
Open Access
Open access
LEP G2548A Polymorphism is Associated with Increased Serum Leptin and Insulin Resistance among T2DM Malaysian Patients
Ali L.A., Jemon K., Ab Latif N., Abu Bakar S., Syed Alwi S.S.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 2
Open Access
Open access
Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis
Liyis B.G., Nolan J., Maharjana M.A.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 16
Open Access
Open access
Serum alpha-1-antitrypsin level in the severity prognosis of systemic lupus erythematosus patients: Systematic exploration of novel biomarker
Khamchun S., Thakaeng C., Na Lampang R.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 3
Open Access
Open access
Oral administration of injectable vitamin K1 in Brodifacoum intoxication
Chu Y., Lin J., Hung D.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 2
Open Access
Open access
Comparison between the analytical sensitivity and clinical performance of two cobas SARS-CoV-2 tests based on high-throughput and point-of-care systems
Lin T., Bui N., Chang Y., Hsu L., Su Y., Chang C., Hong W., Le U.N., Huang S., Lin C.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 5
Open Access
Open access
Anti-Herpes Virus Activity Of Lactobacillus’ Postbiotics
Vilhelmova_Ilieva N., Atanasov G., Simeonova L., Dobreva L., Mancheva K., Trepechova M., Danova S.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 13
Open Access
Open access
Applying Artificial Neural-network Model to Predict Psychiatric Symptoms
Allahyari E., Roustaei N.
Q2
Elsevier
BioMedicine (Netherlands) 2022 citations by CoLab: 8
Open Access
Open access
Study of the D-dimer, C-reactive protein, and autoantibodies markers among HBV infected patients in Babylon province, Iraq
Bayram A.A., Al-Dahmoshi H.O., Al-Khafaji N.S., Al Mammori R.T., Al-Shimmery A.H., Saki M.
Q2
Elsevier
BioMedicine (Netherlands) 2021 citations by CoLab: 3
Open Access
Open access

Top-100

Citing journals

20
40
60
80
100
120
Show all (70 more)
20
40
60
80
100
120

Citing publishers

100
200
300
400
500
600
700
800
900
1000
Show all (70 more)
100
200
300
400
500
600
700
800
900
1000

Publishing organizations

50
100
150
200
250
300
350
Show all (70 more)
50
100
150
200
250
300
350

Publishing organizations in 5 years

1
1

Publishing countries

500
1000
1500
2000
2500
3000
3500
4000
4500
5000
USA, 4640, 24.92%
Italy, 392, 2.11%
United Kingdom, 75, 0.4%
Canada, 65, 0.35%
Germany, 27, 0.15%
Philippines, 27, 0.15%
China, 25, 0.13%
France, 24, 0.13%
Russia, 23, 0.12%
Mexico, 21, 0.11%
Japan, 20, 0.11%
Greece, 19, 0.1%
India, 18, 0.1%
Australia, 13, 0.07%
Turkey, 13, 0.07%
Israel, 10, 0.05%
Panama, 9, 0.05%
South Africa, 9, 0.05%
Belgium, 8, 0.04%
Bulgaria, 8, 0.04%
Republic of Korea, 8, 0.04%
USSR, 8, 0.04%
Portugal, 7, 0.04%
Poland, 6, 0.03%
Puerto Rico, 6, 0.03%
Sweden, 6, 0.03%
Colombia, 5, 0.03%
Uganda, 5, 0.03%
Czech Republic, 5, 0.03%
Argentina, 4, 0.02%
Palestine, 4, 0.02%
Montenegro, 4, 0.02%
Chile, 4, 0.02%
Switzerland, 4, 0.02%
Brazil, 3, 0.02%
Hungary, 3, 0.02%
Haiti, 3, 0.02%
Lebanon, 3, 0.02%
Slovenia, 3, 0.02%
Thailand, 3, 0.02%
Bolivia, 2, 0.01%
Vietnam, 2, 0.01%
Egypt, 2, 0.01%
Iraq, 2, 0.01%
Ireland, 2, 0.01%
Spain, 2, 0.01%
Costa Rica, 2, 0.01%
Malaysia, 2, 0.01%
Nigeria, 2, 0.01%
New Zealand, 2, 0.01%
Peru, 2, 0.01%
Romania, 2, 0.01%
Saudi Arabia, 2, 0.01%
Singapore, 2, 0.01%
Finland, 2, 0.01%
Estonia, 1, 0.01%
Albania, 1, 0.01%
Algeria, 1, 0.01%
Armenia, 1, 0.01%
Bosnia and Herzegovina, 1, 0.01%
Honduras, 1, 0.01%
Zambia, 1, 0.01%
Iran, 1, 0.01%
Libya, 1, 0.01%
Monaco, 1, 0.01%
Netherlands, 1, 0.01%
Norway, 1, 0.01%
Pakistan, 1, 0.01%
Serbia, 1, 0.01%
Trinidad and Tobago, 1, 0.01%
Uruguay, 1, 0.01%
Falkland Islands (Malvinas), 1, 0.01%
Ecuador, 1, 0.01%
Jamaica, 1, 0.01%
Show all (44 more)
500
1000
1500
2000
2500
3000
3500
4000
4500
5000

Publishing countries in 5 years

1
Germany, 1, 0.29%
USA, 1, 0.29%
United Kingdom, 1, 0.29%
Finland, 1, 0.29%
South Africa, 1, 0.29%
1